2-26481015-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP4
This summary comes from the ClinGen Evidence Repository: The filtering allele frequency (the lower threshold of the 95% CI of 232/24628) of the c.1580-6C>T variant in the OTOF gene is 0.843% for African/African-American chromosomes by gnomAD, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). Additionally, splice prediction analysis using MaxEntScan and SpliceAI does not suggest an impact to splicing (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BA1, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA177561/MONDO:0019497/005
Frequency
Consequence
NM_194248.3 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| OTOF | NM_194248.3 | c.1580-6C>T | splice_region_variant, intron_variant | Intron 14 of 46 | ENST00000272371.7 | NP_919224.1 | ||
| OTOF | NM_001287489.2 | c.1580-6C>T | splice_region_variant, intron_variant | Intron 14 of 45 | NP_001274418.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| OTOF | ENST00000272371.7 | c.1580-6C>T | splice_region_variant, intron_variant | Intron 14 of 46 | 1 | NM_194248.3 | ENSP00000272371.2 | |||
| OTOF | ENST00000403946.7 | c.1580-6C>T | splice_region_variant, intron_variant | Intron 14 of 45 | 5 | ENSP00000385255.3 | 
Frequencies
GnomAD3 genomes  0.00287  AC: 437AN: 152204Hom.:  1  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000758  AC: 187AN: 246818 AF XY:  0.000589   show subpopulations 
GnomAD4 exome  AF:  0.000283  AC: 412AN: 1457396Hom.:  4  Cov.: 32 AF XY:  0.000250  AC XY: 181AN XY: 725122 show subpopulations 
Age Distribution
GnomAD4 genome  0.00287  AC: 437AN: 152322Hom.:  1  Cov.: 33 AF XY:  0.00286  AC XY: 213AN XY: 74478 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:3 
- -
- -
- -
not specified    Benign:1 
1580-6C>T in Intron 14 of OTOF: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (25/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs114260271). -
Nonsyndromic genetic hearing loss    Benign:1 
The filtering allele frequency (the lower threshold of the 95% CI of 232/24628) of the c.1580-6C>T variant in the OTOF gene is 0.843% for African/African-American chromosomes by gnomAD, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). Additionally, splice prediction analysis using MaxEntScan and SpliceAI does not suggest an impact to splicing (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BA1, BP4. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at